Dr. Stefanie Greifeneder

Munich Allemagne

Prix à l'honneur

Legal 500 2025

Recommended lawyer for Healthcare and life sciences

Stefanie is an expert in all regulatory, commercial and contractual matters in the pharmaceutical, medical device and biotech sector as well as in compliance-relevant topics in this area. She advises on the drafting and negotiation of complex and cross-border licensing agreements (out-licensing and in-licensing), research and development collaborations, manufacturing and distribution agreements as well as clinical trial agreements and with CROs.

In M&A and private equity transactions in the life sciences sector, she advises on all regulatory and contractual issues.

Coffee Break Life Sciences Start-ups | Our new webinar series

Every third Wednesday of the month in 2025.

CV

Since 2023 Partner, Taylor Wessing

2013 - 2023 Partner, Fieldfisher, Munich

2012 - 2013 Counsel, Salans LLP, Frankfurt am Main

Carrière

Since 2023 Partner, Taylor Wessing

2013 - 2023 Partner, Fieldfisher, Munich

2012 - 2013 Counsel, Salans LLP, Frankfurt am Main

Formation

2004 - 2008 Doctoral degree, dissertation on „Health and Nutrition Claims on Foods“

2004 Admission as a lawyer

2004 Second State Examination, Munich

Langues étrangères

Prix et distinctions

Legal 500 2025

Featured

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

View Stefanie's insights

Cliquer ici pour en savoir plus

Sciences de la vie et Santé

Collaborations between Life Sciences and Tech Companies: A Strategic Path to Digital Transformation

24 mars 2025

par Dr. Stefanie Greifeneder et Dr. Amir-Said Ghassabeh

Synapse - AI in Life Sciences

Selecting your AIA notified body

Manufacturers/providers of medical devices that, according to the EU AI Act, include a high-risk AI system (HRAIS) require a notified body assessment of their technical documentation and/or quality management system should urgently consider which notified body to appoint.

6 mars 2025

par Dr. Stefanie Greifeneder et Alison Dennis

6 de 10 Publications

Cliquer ici pour en savoir plus

Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2025

24 janvier 2025

In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus

Dr. Stefanie Greifeneder

Legal 500 2025

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2025

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

Collaborations between Life Sciences and Tech Companies: A Strategic Path to Digital Transformation

Dr. Stefanie Greifeneder

Legal 500 2025

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Langues étrangères

Prix et distinctions

Legal 500 2025

JUVE Awards 2023

Legal 500 Germany 2024

Actualités et publications récentes

Collaborations between Life Sciences and Tech Companies: A Strategic Path to Digital Transformation

Related news & insights

Taylor Wessing conseille Eiffel Investment Group dans le cadre de la levée de fonds de 15 millions d’euros d’Entech

Court Rulings on Pharmacy Marketing Remain Strict: OLG Frankfurt Prohibits Voucher Advertising

Advising SENISCA on its partnership with L'Oréal

The Critical Medicines Act: A New Pillar of European Pharmaceutical Resilience

China’s Rare Earth Export Controls: Implications for European Life Sciences Companies

Life Sciences as a Security-Relevant Sector: Is Innovation at Risk under European and German FDI Control?

Corporate Venturing in Life Sciences: Making Partnerships Truly Strategic

Higher Regional Court of Frankfurt am Main on online referral of doctors for the prescription of medical cannabis

Request for a preliminary ruling by the BGH to the CJEU on the scope of the duty of care of medical device distributors

Appeal proceedings on the admissibility of granting Rx bonuses to a mail-order pharmacy based in the EU

Autres avocats qui pourraient vous intéresser

Rendez-vous à